✦ LIBER ✦

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

✍ Scribed by Waddell, Tom; Chau, Ian; Cunningham, David; Gonzalez, David; Okines, Alicia Frances Clare; Wotherspoon, Andrew; Saffery, Claire; Middleton, Gary; Wadsley, Jonathan; Ferry, David; Mansoor, Wasat; Crosby, Tom; Coxon, Fareeda; Smith, David; Waters, Justin; Iveson, Timothy; Falk, Stephen; Slater, Sarah; Peckitt, Clare; Barbachano, Yolanda

Book ID: 120231799
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 396 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70096-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and cisplatin with or witho

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

✍ Lordick, Florian; Kang, Yoon-Koo; Chung, Hyun-Cheol; Salman, Pamela; Oh, Sang Ch 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 323 KB

Epirubicin, Oxaliplatin, and Capecitabin

Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial

✍ Okines, A. F. C.; Ashley, S. E.; Cunningham, D.; Oates, J.; Turner, A.; Webb, J. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 122 KB

Gemcitabine and oxaliplatin with or with

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

✍ Jeeyun Lee; Se Hoon Park; Heung-Moon Chang; Jun Suk Kim; Hye Jin Choi; Myung Ah 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 221 KB

Gemcitabine and capecitabine with or wit

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

✍ Middleton, Gary; Silcocks, Paul; Cox, Trevor; Valle, Juan; Wadsley, Jonathan; Pr 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 385 KB

Oxaliplatin, fluorouracil, and leucovori

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

✍ Taieb, Julien; Tabernero, Josep; Mini, Enrico; Subtil, Fabien; Folprecht, Gunnar 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 466 KB

Gemcitabine and oxaliplatin with or with

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

✍ Malka, David; Cervera, Pascale; Foulon, Stéphanie; Trarbach, Tanja; de la Foucha 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 296 KB